The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PD-1/PD-L1 pathway as a target for cancer immunotherapy: Safety and clinical activity of BMS-936559, an anti-PD-L1 antibody, in patients with solid tumors.
Scott S. Tykodi
Research Funding - Bristol-Myers Squibb
Julie R. Brahmer
No relevant relationships to disclose
Wen-Jen Hwu
Research Funding - Bristol-Myers Squibb
Laura Q. Chow
Research Funding - Bristol-Myers Squibb
Suzanne Louise Topalian
Consultant or Advisory Role - Amplimmune (I); Bristol-Myers Squibb (B,U)
Research Funding - Bristol-Myers Squibb
Patrick Hwu
No relevant relationships to disclose
Kunle Odunsi
No relevant relationships to disclose
Luis H. Camacho
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
John S Kauh
No relevant relationships to disclose
Henry Clement Pitot
No relevant relationships to disclose
Omid Hamid
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Drew M. Pardoll
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb (U)
Shruti Agrawal
Employment or Leadership Position - Bristol-Myers Squibb
Susan Parker
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Stacie Goldberg
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jon Wigginton
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb